Literature DB >> 24222969

Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn's disease.

Fa-Ming Zhang1, Hong-Gang Wang, Min Wang, Bo-Ta Cui, Zhi-Ning Fan, Guo-Zhong Ji.   

Abstract

The concept of fecal microbiota transplantation (FMT) has been used in traditional Chinese medicine at least since the 4(th) century. Evidence from recent human studies strongly supports the link between intestinal bacteria and inflammatory bowel disease. We proposed that standardized FMT might be a promising rescue therapy for refractory inflammatory bowel disease. However, there were no reports of FMT used in patients with severe Crohn's disease (CD). Here, we report the successful treatment of standardized FMT as a rescue therapy for a case of refractory CD complicated with fistula, residual Barium sulfate and formation of intraperitoneal large inflammatory mass. As far as we know, this is the first case of severe CD treated using FMT through mid-gut.

Entities:  

Keywords:  Crohn’s disease; Fecal microbiota transplantation; Fistula; Inflammatory bowel disease; Rescue therapy

Mesh:

Year:  2013        PMID: 24222969      PMCID: PMC3819561          DOI: 10.3748/wjg.v19.i41.7213

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

1.  A human gut microbial gene catalogue established by metagenomic sequencing.

Authors:  Junjie Qin; Ruiqiang Li; Jeroen Raes; Manimozhiyan Arumugam; Kristoffer Solvsten Burgdorf; Chaysavanh Manichanh; Trine Nielsen; Nicolas Pons; Florence Levenez; Takuji Yamada; Daniel R Mende; Junhua Li; Junming Xu; Shaochuan Li; Dongfang Li; Jianjun Cao; Bo Wang; Huiqing Liang; Huisong Zheng; Yinlong Xie; Julien Tap; Patricia Lepage; Marcelo Bertalan; Jean-Michel Batto; Torben Hansen; Denis Le Paslier; Allan Linneberg; H Bjørn Nielsen; Eric Pelletier; Pierre Renault; Thomas Sicheritz-Ponten; Keith Turner; Hongmei Zhu; Chang Yu; Shengting Li; Min Jian; Yan Zhou; Yingrui Li; Xiuqing Zhang; Songgang Li; Nan Qin; Huanming Yang; Jian Wang; Søren Brunak; Joel Doré; Francisco Guarner; Karsten Kristiansen; Oluf Pedersen; Julian Parkhill; Jean Weissenbach; Peer Bork; S Dusko Ehrlich; Jun Wang
Journal:  Nature       Date:  2010-03-04       Impact factor: 49.962

Review 2.  Family studies in Crohn's disease: new horizons in understanding disease pathogenesis, risk and prevention.

Authors:  Charlotte R Hedin; Andrew J Stagg; Kevin Whelan; James O Lindsay
Journal:  Gut       Date:  2011-05-11       Impact factor: 23.059

3.  Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome?

Authors:  T J Borody; L George; P Andrews; S Brandl; S Noonan; P Cole; L Hyland; A Morgan; J Maysey; D Moore-Jones
Journal:  Med J Aust       Date:  1989-05-15       Impact factor: 7.738

Review 4.  Fecal microbiota transplantation and emerging applications.

Authors:  Thomas J Borody; Alexander Khoruts
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-12-20       Impact factor: 46.802

5.  Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease.

Authors:  S C Ng; J L Benjamin; N E McCarthy; C R H Hedin; A Koutsoumpas; S Plamondon; C L Price; A L Hart; M A Kamm; A Forbes; S C Knight; J O Lindsay; K Whelan; A J Stagg
Journal:  Inflamm Bowel Dis       Date:  2010-12-22       Impact factor: 5.325

6.  Management of Crohn's disease in adults.

Authors:  Gary R Lichtenstein; Stephen B Hanauer; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2009-01-06       Impact factor: 10.864

7.  Treatment of ulcerative colitis using fecal bacteriotherapy.

Authors:  Thomas J Borody; Eloise F Warren; Sharyn Leis; Rosa Surace; Ori Ashman
Journal:  J Clin Gastroenterol       Date:  2003-07       Impact factor: 3.062

8.  Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection.

Authors:  Lauren M De Leon; James B Watson; Colleen R Kelly
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-10       Impact factor: 11.382

Review 9.  Diagnosis and management of fistulizing Crohn's disease.

Authors:  Ole Haagen Nielsen; Gerhard Rogler; Dieter Hahnloser; Ole Østergaard Thomsen
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2009-01-20

10.  Human gut microbiome viewed across age and geography.

Authors:  Tanya Yatsunenko; Federico E Rey; Mark J Manary; Indi Trehan; Maria Gloria Dominguez-Bello; Monica Contreras; Magda Magris; Glida Hidalgo; Robert N Baldassano; Andrey P Anokhin; Andrew C Heath; Barbara Warner; Jens Reeder; Justin Kuczynski; J Gregory Caporaso; Catherine A Lozupone; Christian Lauber; Jose Carlos Clemente; Dan Knights; Rob Knight; Jeffrey I Gordon
Journal:  Nature       Date:  2012-05-09       Impact factor: 49.962

View more
  46 in total

1.  Fecal Microbiota Transplant via Endoscopic Delivering Through Small Intestine and Colon: No Difference for Crohn's Disease.

Authors:  Zhenyu Yang; Chibin Bu; Wei Yuan; Zhaohua Shen; Yongsheng Quan; Shuai Wu; Changxin Zhu; Xiaoyan Wang
Journal:  Dig Dis Sci       Date:  2019-07-31       Impact factor: 3.199

Review 2.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

3.  Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease.

Authors:  Severine Vermeire; Marie Joossens; Kristin Verbeke; Jun Wang; Kathleen Machiels; João Sabino; Marc Ferrante; Gert Van Assche; Paul Rutgeerts; Jeroen Raes
Journal:  J Crohns Colitis       Date:  2015-10-29       Impact factor: 9.071

Review 4.  Deciphering the tête-à-tête between the microbiota and the immune system.

Authors:  Neeraj K Surana; Dennis L Kasper
Journal:  J Clin Invest       Date:  2014-07-18       Impact factor: 14.808

Review 5.  Infectious etiopathogenesis of Crohn's disease.

Authors:  Jessica Carrière; Arlette Darfeuille-Michaud; Hang Thi Thu Nguyen
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 6.  The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions.

Authors:  Stephen M Vindigni; Timothy L Zisman; David L Suskind; Christopher J Damman
Journal:  Therap Adv Gastroenterol       Date:  2016-04-19       Impact factor: 4.409

Review 7.  The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis.

Authors:  Taha Qazi; Thelina Amaratunga; Edward L Barnes; Monika Fischer; Zain Kassam; Jessica R Allegretti
Journal:  Gut Microbes       Date:  2017-09-12

Review 8.  Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics.

Authors:  Amosy E M'Koma
Journal:  World J Gastrointest Surg       Date:  2014-11-27

Review 9.  Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.

Authors:  Alexa R Weingarden; Byron P Vaughn
Journal:  Gut Microbes       Date:  2017-02-10

Review 10.  The effect of NOD2 on the microbiota in Crohn's disease.

Authors:  Mackenzie L Lauro; Jason M Burch; Catherine Leimkuhler Grimes
Journal:  Curr Opin Biotechnol       Date:  2016-03-29       Impact factor: 9.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.